Clinical Trial Update: Minimally Invasive Surgical Therapy for BPH [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia sponsored by NIDDK has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: TERMINATED